Date: Nov 18, 2019
Keller and Heckman Partner, Rick Stearns, will present “What is FDA’s Role in the Regulation of CBD?” at the FDLI: Legal & Practical Issues in the Evolving World of Cannabis Regulation on November 18, 2019 in Washington D.C. This conference will identify uncertainties in CBD and cannabis regulation and guide attendees on how to move forward despite this uncertainty. The first day of the conference will engage in level-setting regarding the current federal and state regulatory landscape of CBD and cannabis products. On the second day, industry experts will discuss what issues are in flux, risks and challenges for manufacturers, and what potential solutions look like for the future of regulation.
For more information, click here.